MD, FRCPC, CSPQ
With this special issue of the Journal of Current Clinical Care we aim to provide community healthcare professionals with practical clinical insight and support in managing patients with ulcerative colitis.
MD
Informed patients are one of the most important assets available in the management of patients with ulcerative colitis.
MD, PhD
5-Aminosalicylates (5-ASAs) are considered first-line therapy for mild to moderate ulcerative colitis because of their proven effectiveness and safety profile, even in pregnancy.
MD, MS, FRCPC
A 28-year-old male presented to our office for a consultation about his bloody bowel movements. Colonoscopy revealed moderately active left-sided ulcerative colitis extending from the anal verge up to the mid-descending colon.
MD
Although medical therapy for ulcerative colitis is usually effective at inducing clinical remission, numerous studies have shown that patients in clinical remission may have ongoing and varying degrees of mucosal inflammation.
Advertisement
From time-to-time we select a topic and present the information and facts in an exciting and visually informative format.
MD, CCFP, FCFP, FRCPC
For instance, improving computer and imaging technology has translated into imaging developments that can be used to benefit patients.
MD, CCFP, ABFM
As the population is aging, physicians from all specialties are expected to see more older adults at their outpatient practices and in the acute settings.